Roche's (ROP SW) obesity product development head says the latest obesity drug results are reassuring, is confident that enicepatide will achieve higher weight loss in new studies

Newsquawk StaffPublished On the live feed at 8 more headlines followed before this page went public
Newsquawk headlinesUTC

3M (MMM) guides Q2 organic growth solidly above 3%, with management saying it is very confident given how far it is into the quarter and as Q1 order backlog strength is converting into revenue

US Bancorp (USB) current quarter NII expected towards the upper end of +6-7% Y/Y; fee rev. is expected above the prior +6-7% Y/Y range, assisted by capital markets strength

Roche's (ROP SW) obesity product development head says the latest obesity drug results are reassuring, is confident that enicepatide will achieve higher weight loss in new studies

US EQUITY OPEN: Indices see two-way trade post-CPI as Tech rout takes a breath

US Senate Republican leader Thune says that "most" Republican senators want the US to finish the job with reference to Iran, speaking to Fox News

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free